Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Search content at Experts@Minnesota
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Datasets
Press/Media
Activities
Fellowships, Honors, and Prizes
Impacts
Imipramine compliance in adolescents
Gail A. Bernstein
, Lesley K. Anderson
, Joel M. Hektner
, George M. Realmuto
Psychiatry & Behavioral Sciences
Research output
:
Contribution to journal
›
Article
›
peer-review
31
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Imipramine compliance in adolescents'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Imipramine
100%
Placebo
66%
Psychiatrists
50%
Family Cohesion
50%
Family Adaptability
50%
Non-associated
33%
Family Functioning
33%
Evaluation Scale
33%
Global Improvement
33%
Oppositional Defiant Disorder
33%
Medication Compliance
33%
Clinical Trials
16%
Depressed Adolescents
16%
Dropout
16%
Cognitive Behavioral Therapy
16%
Medication Adherence
16%
Logistic Regression
16%
Disengagement
16%
Accuracy Rate
16%
Independent Evaluator
16%
Anxious-depressed
16%
Non-adherence
16%
Treatment Conditions
16%
School Refusal
16%
Pill Count
16%
Family Type
16%
Expectancy Bias
16%
Rating Changes
16%
Placebo Groups
16%
Nursing and Health Professions
Imipramine
100%
Side Effect
100%
Youth
100%
Placebo
83%
Psychiatrist
50%
Family Functioning
33%
Medication Compliance
33%
Oppositional Defiant Disorder
33%
Rigidity
16%
Pill
16%
Logistic Regression Analysis
16%
Cognitive Behavioral Therapy
16%
Clinical Trial
16%
Psychology
Adolescence
100%
Oppositional Defiant Disorder
40%
Clinical Trial
20%
Cognitive Behavioral Therapy
20%
School Refusal
20%